e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities
Hannah Yejin Kim, Evan Ulbricht, Yu Kyung Ahn, Isabelle Sarah Gillooly, Kher Jing Lee, Jessica Lieu, William Nguyen, Sylvia Young, Jin-Gun Cho, Jan-Willem Alffenaar
Source:
Eur Respir J, 57 (1) 2002349; 10.1183/13993003.02349-2020
Journal Issue:
January
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Hannah Yejin Kim, Evan Ulbricht, Yu Kyung Ahn, Isabelle Sarah Gillooly, Kher Jing Lee, Jessica Lieu, William Nguyen, Sylvia Young, Jin-Gun Cho, Jan-Willem Alffenaar. Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities. Eur Respir J, 57 (1) 2002349; 10.1183/13993003.02349-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Emerging classes of drugs for the treatment of obstructive lung disease
Eosinophils and airway nerves in asthma
Related content which might interest you:
Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment?
Source: Eur Respir J 2013; 42: 1449-1453
Year: 2013
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Source: Eur Respir J 2011; 38: 516-528
Year: 2011
Screening and monitoring of tuberculosis in patients on biologics treatment
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012
Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
Rational monitoring of COPD: where do current clinical guidelines stand?
Source: Eur Respir J 2007; 29: 1078-1081
Year: 2007
The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection
Source: Eur Respir J 2015; 45: 569-571
Year: 2015
The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection
Source: Eur Respir J 2015; 45: 571-574
Year: 2015
Monitoring results of diagnostics and treatment of new TB patients in Uliyanovsk region
Source: Annual Congress 2010 - Global tuberculosis control
Year: 2010
Predicting outcomes and drug resistance with standardised treatment of active tuberculosis
Source: Eur Respir J 2010; 36: 870-877
Year: 2010
Impact of continuous medical education (CME) training on improving diagnostic and therapeutic approach to respiratory infections: results of the MATerA project
Source: Eur Respir J 2004; 24: Suppl. 48, 86s
Year: 2004
Clinical management of COPD: recommended practice including the place of antibiotics
Source: Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis
Year: 2008
Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultation
Source: Eur Respir J 2014; 44: 1412-1417
Year: 2014
IGRA testing to diagnose TB disease and infection. What is new in clinical practice and for programmatic management
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012
Enhancing patient safety: New WHO guidance on pharmacovigilance in tuberculosis care
Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features
Year: 2012
Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance
Source: Eur Respir J 2012; 39: 802-804
Year: 2012
Innovative tools for diagnosis and prevention of paediatric tuberculosis
Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis
Year: 2019
Physician perspectives: monitoring severe AATD and optimising treatment
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017
Screening and monitoring of TB infection in rheumatological patients on biologics therapy
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021
Integrating patients with respiratory and cardiac disease in one rehabilitation programme: clinical outcomes of a pragmatic service evaluation.
Source: International Congress 2019 – Innovations in care for chronic respiratory conditions
Year: 2019
Appreciation efficiency of standard and alternative antituberculosis preventive therapy in children from different tuberculosis infection sources
Source: Eur Respir J 2006; 28: Suppl. 50, 28s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept